Organ transplant patients usually have to take immunosuppressive drugs for the rest of their lives to prevent their bodies from rejecting the organs. This therapy suppresses the physiological immune response to tumors and infections. The therapeutic goal for this patient group is to achieve an optimal balance between immunocompetence and [...]

Hematological stem cell transplantation (HSCT) is one of the most important treatments for haematological malignancies. Two major complications after stem cell transplantations are the development of graft-versus-host disease (GvHD) and the reactivation of the human cytomegalovirus (HCMV), which occurs in 60% of seropositive patients. This reactivation can have severe consequences [...]